sur I2S (EPA:ALI2S)
I2S 2025 half-year results: a mixed context
i2S has announced revenue of €7.4 million for the first half of 2025, marking a 13% decrease compared to the same period in 2024. This decrease, although significant, is mitigated by a less unfavorable second quarter with a decline of only 6.5% compared to the first.
In detail, the i2S Medcare and i2S Orphie segments recorded increases of 15% and 17% respectively. This momentum was partially offset by a significant decline in sales of i2S DigiBook and i2S Vision, impacting the overall figure. Export activities accounted for 69% of revenue but also suffered an 18% contraction.
The positive outlook for i2S is based on strong demand for the Orphie and Twiga ranges, as well as new strategic contracts that could boost growth. However, geopolitical uncertainty remains a variable to monitor.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de I2S